Notably, depletion of tNASP reportedly inhibits proliferation in prostate cancer PC-3 cells and renal cell carcinoma cells (Alekseev et al., 2011; Fang et al., 2015), echoing the cell cycle defects of Srsf10-cKO spermatogonia. Here, SRSF10 is linked to Familial prostate cancer.